Association between plasma B-type natriuretic peptide and anaemia in heart failure with or without ischaemic heart disease: a retrospective study
Authors:
Open Access
Abstract
Objectives Anaemia is a risk of worsening heart failure. However, anaemia sometimes remains undetected because the superficial cardiac function does not precisely reflect the adverse impact of anaemia. Plasma B-type natriuretic peptide (BNP) could be helpful in these cases. However, the direct anaemic effects on BNP remain unknown. Herein, we compared the direct effect of anaemia on BNP and left ventricular ejection fraction (LVEF) using an advanced statistical procedure. Design A retrospective study. Setting Secondary care (cardiology), single-centre study. Participants The study consisted of 3756 inpatients, including 684 without ischaemic heart disease (IHD) and 3072 with IHD. Primary and secondary outcome measures Relationship between plasma BNP levels and LVEF values. Results A path model was constructed to simultaneously examine the adverse impact of anaemia on LVEF and plasma BNP, allowing for renal function. The path model revealed that LVEF increased in response to low haemoglobin (Hb), and the phenomenon was prominent in non-IHD (standardised regression coefficients (St.β): −0.264, pConclusion The current study demonstrated that anaemia was a substantial risk for worsening cardiac overload as estimated by plasma BNP. The anaemic response of LVEF likely changed depending on underlying cardiac disorders (IHD or not). However, the response of BNP was robustly observed.Keywords
This publication has 38 references indexed in Scilit:
- Cardiac remodeling in response to chronic iron deficiencyJournal Of Hypertension, 2015
- Anemia and Its Relationship to Clinical Outcome in Heart FailureCirculation, 2004
- Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trialEuropean Heart Journal, 2004
- Anemia Is Common in Heart Failure and Is Associated With Poor OutcomesCirculation, 2003
- Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failureJACC, 2002
- Effect of Interleukin-1β on Cardiac Hypertrophy and Production of Natriuretic Peptides in Rat Cardiocyte CultureJournal of Molecular and Cellular Cardiology, 1999
- Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.Journal of Clinical Investigation, 1995
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991
- A new natriuretic peptide in porcine brainNature, 1988